END-STAGE KIDNEY DISEASE (ESKD)
Clinical trials for END-STAGE KIDNEY DISEASE (ESKD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE KIDNEY DISEASE (ESKD) trials appear
Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE (ESKD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dialysis upgrade could protect bones in kidney patients
Disease control Not yet recruitingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can better manage bone and mineral problems common in people with end-stage kidney disease. Thirty adults on maintenance dialysis will try both the new and standard filters for three months each. R…
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control Not yet recruitingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can reduce inflammation and improve heart function better than the standard filter in people with end-stage kidney disease. Thirty adults on maintenance hemodialysis will use each filter for three …
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Dialysis showdown: which method protects heart and bones best?
Knowledge-focused Not yet recruitingThis study looks at how different types of dialysis affect heart health, bone metabolism, inflammation, and quality of life in people with end-stage kidney disease. Researchers will compare patients on hemodialysis, continuous ambulatory peritoneal dialysis, and automated periton…
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Massive kidney trial aims to revolutionize how we test treatments
Knowledge-focused Not yet recruitingAPT-KIDNEY is a large, flexible clinical trial platform designed to test multiple treatments for advanced kidney disease more efficiently. It will enroll up to 5,000 adults with severe kidney problems or those on dialysis. By using electronic health records and adaptive methods, …
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Phase: NA • Sponsor: Nicholas Carlson • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC